Balyasny Asset Management LLC Rocket Pharmaceuticals, Inc. Transaction History

Balyasny Asset Management LLC

  • $58 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023
BUY
$15.07 - $24.05 $515,469 - $822,630
34,205 New
34,205 $700,000
Q4 2022

Feb 14, 2023
SELL
$15.5 - $22.76 $763,034 - $1.12 Million
-49,228 Reduced 98.91%
542 $10,000
Q3 2022

Nov 14, 2022
BUY
$12.37 - $18.41 $615,654 - $916,265
49,770 New
49,770 $794,000

Others Institutions Holding RCKT

# of Institutions
210
Shares Held
93.2M
Call Options Held
319K
Put Options Held
70.3K
View Full List

About ROCKET PHARMACEUTICALS, INC.

RCKT Quotes by TradingView
  • Ticker RCKT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 75,683,696
  • Market Cap $788M
  • Description
  • Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...
More about RCKT
Track This Portfolio

Track Balyasny Asset Management LLC Portfolio

Follow Balyasny Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Balyasny Asset Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email